Systemic determinants of brain health in ageing
World Health Organization. Optimizing brain health across the life course: WHO position paper (WHO, 2022).
Bassetti, C. L. A. et al. The European Academy of Neurology Brain Health Strategy: one brain, one life, one approach. Eur. J. Neurol. 29, 2559–2566 (2022).
Google Scholar
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105–e125 (2022).
Google Scholar
Cahill, S. WHO’s global action plan on the public health response to dementia: some challenges and opportunities. Aging Ment. Health 24, 197–199 (2020).
Google Scholar
Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10, S10–S17 (2004).
Google Scholar
van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. 388, 9–21 (2023).
Google Scholar
Mintun, M. A. et al. Donanemab in early Alzheimer’s disease. N. Engl. J. Med. 384, 1691–1704 (2021).
Google Scholar
Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413–446 (2020).
Google Scholar
Ely, E. W., Siegel, M. D. & Inouye, S. K. Delirium in the intensive care unit: an under-recognized syndrome of organ dysfunction. Semin. Respir. Crit. Care Med. 22, 115–126 (2001).
Google Scholar
Wolters, F. J. et al. Coronary heart disease, heart failure, and the risk of dementia: a systematic review and meta-analysis. Alzheimers Dement. 14, 1493–1504 (2018).
Google Scholar
Tang, X. et al. Association of kidney function and brain health: a systematic review and meta-analysis of cohort studies. Ageing Res. Rev. 82, 101762 (2022).
Google Scholar
Pathan, S. S. et al. Association of lung function with cognitive decline and dementia: the Atherosclerosis Risk in Communities (ARIC) Study. Eur. J. Neurol. 18, 888–898 (2011).
Google Scholar
Guay-Gagnon, M. et al. Sleep apnea and the risk of dementia: a systematic review and meta-analysis. J. Sleep Res. 31, e13589 (2022).
Google Scholar
Yuan, S. et al. Digestive system diseases, genetic risk, and incident dementia: a prospective cohort study. Am. J. Prev. Med. 66, 516–525 (2024).
Google Scholar
Parikh, N. S. et al. Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank study. Alzheimers Dement. 19, 1518–1528 (2023).
Google Scholar
Xue, M. et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res. Rev. 55, 100944 (2019).
Google Scholar
Gorelick, P. B. et al. Defining optimal brain health in adults: a presidential advisory from the American Heart Association/American Stroke Association. Stroke 48, e284–e303 (2017).
Google Scholar
Johansen, M. C. et al. Association between acute myocardial infarction and cognition. JAMA Neurol. 80, 723–731 (2023).
Google Scholar
Xie, W., Zheng, F., Yan, L. & Zhong, B. Cognitive decline before and after incident coronary events. J. Am. Coll. Cardiol. 73, 3041–3050 (2019).
Google Scholar
Greaves, D. et al. Cognitive outcomes following coronary artery bypass grafting: a systematic review and meta-analysis of 91,829 patients. Int. J. Cardiol. 289, 43–49 (2019).
Google Scholar
Selnes, O. A. et al. Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann. Neurol. 63, 581–590 (2008).
Google Scholar
Vishwanath, S. et al. Cognitive decline and risk of dementia in individuals with heart failure: a systematic review and meta-analysis. J. Card. Fail. 28, 1337–1348 (2022).
Google Scholar
Kamel, H. et al. Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study). Stroke 49, 980–986 (2018).
Google Scholar
Kamel, H. et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke 46, 711–716 (2015).
Google Scholar
Johansen, M. C. et al. Risk of dementia associated with atrial cardiopathy: the ARIC study. J. Am. Heart Assoc. 11, e025646 (2022).
Google Scholar
Johansen, M. C. et al. Associations of echocardiography markers and vascular brain lesions: the ARIC Study. J. Am. Heart Assoc. 7, e008992 (2018).
Google Scholar
Yoshida, Y. et al. Subclinical left ventricular systolic dysfunction and incident stroke in the elderly: long-term findings from cardiovascular abnormalities and brain lesions. Eur. Heart J. Cardiovasc. Imaging 24, 522–531 (2023).
Google Scholar
Debette, S., Schilling, S., Duperron, M. G., Larsson, S. C. & Markus, H. S. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol. 76, 81–94 (2018).
Google Scholar
Mejia-Renteria, H. et al. Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study). Eur. Heart J. 44, 113–125 (2023).
Google Scholar
Levin, A. & Stevens, P. E. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 85, 49–61 (2014).
Google Scholar
GBD Chronic Kidney Disease Collaboration. Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).
Google Scholar
Trocchi, P., Girndt, M., Scheidt-Nave, C., Markau, S. & Stang, A. Impact of the estimation equation for GFR on population-based prevalence estimates of kidney dysfunction. BMC Nephrol. 18, 341 (2017).
Google Scholar
Kar, S., Paglialunga, S. & Islam, R. Cystatin C is a more reliable biomarker for determining eGFR to support drug development studies. J. Clin. Pharmacol. 58, 1239–1247 (2018).
Google Scholar
Scheppach, J. B. et al. Albuminuria and estimated GFR as risk factors for dementia in midlife and older age: findings from the ARIC study. Am. J. Kidney Dis. 76, 775–783 (2020).
Google Scholar
Nam, G. E. et al. Chronic renal dysfunction, proteinuria, and risk of Parkinson’s disease in the elderly. Mov. Disord. 34, 1184–1191 (2019).
Google Scholar
Scheppach, J. B. et al. Association of kidney function measures with signs of neurodegeneration and small vessel disease on brain magnetic resonance imaging: the atherosclerosis risk in communities (ARIC) study. Am. J. Kidney Dis. 81, 261–269.e1 (2023).
Google Scholar
Sedaghat, S. et al. The association of kidney function with plasma amyloid-β levels and brain amyloid deposition. J. Alzheimers Dis. 92, 229–239 (2023).
Google Scholar
Janelidze, S., Barthelemy, N. R., He, Y., Bateman, R. J. & Hansson, O. Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated tau to total tau ratios. JAMA Neurol. 80, 516–522 (2023).
Google Scholar
Lutsey, P. L. et al. Impaired lung function, lung disease, and risk of incident dementia. Am. J. Respir. Crit. Care Med. 199, 1385–1396 (2019).
Google Scholar
Xiao, T. et al. Lung function impairment and the risk of incident dementia: the Rotterdam study. J. Alzheimers Dis. 82, 621–630 (2021).
Google Scholar
Peng, Y. H. et al. Adult asthma increases dementia risk: a nationwide cohort study. J. Epidemiol. Community Health 69, 123–128 (2015).
Google Scholar
Frenzel, S. et al. Associations of pulmonary function with MRI brain volumes: a coordinated multi-study analysis. J. Alzheimers Dis. 90, 1073–1083 (2022).
Google Scholar
Zhang, B. et al. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut 70, 85–91 (2021).
Google Scholar
Gau, S. Y., Lai, J. N., Yip, H. T., Wu, M. C. & Wei, J. C. Higher dementia risk in people with gastroesophageal reflux disease: a real-world evidence. Front. Aging Neurosci. 14, 830729 (2022).
Google Scholar
Chen, C. H., Lin, C. L. & Kao, C. H. Irritable bowel syndrome is associated with an increased risk of dementia: a nationwide population-based study. PLoS ONE 11, e0144589 (2016).
Google Scholar
Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877–2013 (2019).
Google Scholar
Adewuyi, E. O., O’Brien, E. K., Nyholt, D. R., Porter, T. & Laws, S. M. A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer’s disease and gastrointestinal tract disorders. Commun. Biol. 5, 691 (2022).
Google Scholar
Vogt, N. M. et al. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep. 7, 13537 (2017).
Google Scholar
Seo, D. O. et al. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science 379, eadd1236 (2023).
Google Scholar
Dodiya, H. B. et al. Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer’s transgenic mice. Sci. Rep. 10, 8183 (2020).
Google Scholar
Warnecke, T., Schafer, K. H., Claus, I., Del Tredici, K. & Jost, W. H. Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 8, 31 (2022).
Google Scholar
Hu, W. et al. Autonomic symptoms are predictive of dementia with Lewy bodies. Parkinsonism Relat. Disord. 95, 1–4 (2022).
Google Scholar
Doi, H. et al. Gastrointestinal function in dementia with Lewy bodies: a comparison with Parkinson disease. Clin. Auton. Res. 29, 633–638 (2019).
Google Scholar
Camacho, M. et al. Early constipation predicts faster dementia onset in Parkinson’s disease. NPJ Parkinsons Dis. 7, 45 (2021).
Google Scholar
Braak, H. et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24, 197–211 (2003).
Google Scholar
Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413–1419 (1999).
Google Scholar
Sanyal, A. J. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 16, 377–386 (2019).
Google Scholar
Harris, R., Harman, D. J., Card, T. R., Aithal, G. P. & Guha, I. N. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. Lancet Gastroenterol. Hepatol. 2, 288–297 (2017).
Google Scholar
Allwright, M. et al. Ranking the risk factors for Alzheimer’s disease; findings from the UK Biobank study. Aging Brain 3, 100081 (2023).
Google Scholar
Xiao, T., van Kleef, L. A., Ikram, M. K., de Knegt, R. J. & Ikram, M. A. Association of nonalcoholic fatty liver disease and fibrosis with incident dementia and cognition: the Rotterdam study. Neurology 99, e565–e573 (2022).
Google Scholar
Shang, Y. et al. Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction. JHEP Rep. 3, 100218 (2021).
Google Scholar
Weinstein, G. et al. Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: the Cross-Cohort Collaboration. Eur. J. Neurol. 31, e16048 (2024).
Google Scholar
Parikh, N. S. et al. Association between liver fibrosis and incident dementia in the UK Biobank study. Eur. J. Neurol. 29, 2622–2630 (2022).
Google Scholar
Weinstein, G. et al. Non-alcoholic fatty liver disease, liver fibrosis, and regional amyloid-β and tau pathology in middle-aged adults: the Framingham study. J. Alzheimers Dis. 86, 1371–1383 (2022).
Google Scholar
Jeong, S. M. et al. Favorable impact of non-alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population. Eur. J. Neurol. 26, 1471–1478 (2019).
Google Scholar
Jang, H. et al. Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals. Sci. Rep. 9, 1814 (2019).
Google Scholar
Petta, S. et al. The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease. Medicine 95, e3446 (2016).
Google Scholar
Yan, M. et al. Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal. Transduct. Target. Ther. 8, 443 (2023).
Google Scholar
Hiller-Sturmhofel, S. & Bartke, A. The endocrine system: an overview. Alcohol Health Res. World 22, 153–164 (1998).
Google Scholar
Biessels, G. J. & Despa, F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat. Rev. Endocrinol. 14, 591–604 (2018).
Google Scholar
Crane, P. K. et al. Glucose levels and risk of dementia. N. Engl. J. Med. 369, 540–548 (2013).
Google Scholar
Moran, C. et al. Glycemic control over multiple decades and dementia risk in people with type 2 diabetes. JAMA Neurol. 80, 597–604 (2023).
Google Scholar
Gottesman, R. F. et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA 317, 1443–1450 (2017).
Google Scholar
Moran, C. et al. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology 85, 1123–1130 (2015).
Google Scholar
Abner, E. L. et al. Diabetes is associated with cerebrovascular but not Alzheimer’s disease neuropathology. Alzheimers Dement. 12, 882–889 (2016).
Google Scholar
Dos Santos Matioli, M. N. P. et al. Diabetes is not associated with Alzheimer’s disease neuropathology. J. Alzheimers Dis. 60, 1035–1043 (2017).
Google Scholar
Takenoshita, N. et al. Amyloid and tau positron emission tomography in suggested diabetesrelated dementia. Curr. Alzheimer Res. 15, 1062–1069 (2018).
Google Scholar
Priest, C. & Tontonoz, P. Inter-organ cross-talk in metabolic syndrome. Nat. Metab. 1, 1177–1188 (2019).
Google Scholar
Davidson, T. L. & Stevenson, R. J. Vulnerability of the hippocampus to insults: links to blood-brain barrier dysfunction. Int. J. Mol. Sci. 25, 1991 (2024).
Google Scholar
Raz, L. et al. Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction. Neurobiol. Dis. 126, 124–136 (2019).
Google Scholar
Bailey, D. M. et al. Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans. J. Cereb. Blood Flow Metab. 42, 1120–1135 (2022).
Google Scholar
Wardlaw, J. M., Smith, C. & Dichgans, M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 18, 684–696 (2019).
Google Scholar
Ding, H. et al. Hypercapnia exacerbates the disruption of the blood-brain barrier by inducing interleukin-1β overproduction in the blood of hypoxemic adult rats. Int. J. Mol. Med. 46, 762–772 (2020).
Google Scholar
Yang, W. et al. Effects of acute systemic hypoxia and hypercapnia on brain damage in a rat model of hypoxia-ischemia. PLoS ONE 11, e0167359 (2016).
Google Scholar
Dodd, J. W., Getov, S. V. & Jones, P. W. Cognitive function in COPD. Eur. Respir. J. 35, 913–922 (2010).
Google Scholar
Shim, T. S. et al. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest 120, 1506–1513 (2001).
Google Scholar
Li, H. et al. Abnormal intrinsic functional hubs and connectivity in stable patients with COPD: a resting-state MRI study. Brain Imaging Behav. 14, 573–585 (2020).
Google Scholar
King, P. T. Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer. Clin. Transl. Med. 4, 68 (2015).
Google Scholar
Rajendran, P. et al. The vascular endothelium and human diseases. Int. J. Biol. Sci. 9, 1057–1069 (2013).
Google Scholar
Iadecola, C. The pathobiology of vascular dementia. Neuron 80, 844–866 (2013).
Google Scholar
Schaeffer, S. & Iadecola, C. Revisiting the neurovascular unit. Nat. Neurosci. 24, 1198–1209 (2021).
Google Scholar
Wei, H. et al. Vascular endothelial cells: a fundamental approach for brain waste clearance. Brain 146, 1299–1315 (2023).
Google Scholar
Iadecola, C. et al. The neurovasculome: key roles in brain health and cognitive impairment: a scientific statement from the American Heart Association/ American Stroke Association. Stroke 54, e251–e271 (2023).
Google Scholar
Katusic, Z. S., d’Uscio, L. V. & He, T. Emerging roles of endothelial nitric oxide in preservation of cognitive health. Stroke 54, 686–696 (2023).
Google Scholar
Nasiri-Ansari, N. et al. Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review. Cells 11, 2511 (2022).
Google Scholar
Xu, S. et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol. Rev. 73, 924–967 (2021).
Google Scholar
Roumeliotis, S., Mallamaci, F. & Zoccali, C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update. J. Clin. Med. 9, 2359 (2020).
Google Scholar
Gallo, G. & Savoia, C. New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications. Int. J. Mol. Sci. 25, 2973 (2024).
Google Scholar
Badji, A., Cohen-Adad, J. & Girouard, H. Relationship between arterial stiffness index, pulse pressure, and magnetic resonance imaging markers of white matter integrity: a UK Biobank study. Front. Aging Neurosci. 14, 856782 (2022).
Google Scholar
Zanoli, L. et al. Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. J. Hypertension 38, 1682–1698 (2020).
Google Scholar
Wilkinson, I. B., Franklin, S. S. & Cockcroft, J. R. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 44, 112–116 (2004).
Google Scholar
Lacolley, P., Regnault, V. & Laurent, S. Mechanisms of arterial stiffening: from mechanotransduction to epigenetics. Arterioscler. Thromb. Vasc. Biol. 40, 1055–1062 (2020).
Google Scholar
Arai, K. & Lo, E. H. Wiring and plumbing: oligodendrocyte precursors and angiogenesis in the oligovascular niche. J. Cereb. Blood Flow Metab. 41, 2132–2133 (2021).
Google Scholar
Yousef, H. et al. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1. Nat. Med. 25, 988–1000 (2019).
Google Scholar
Toya, T. et al. Impact of peripheral microvascular endothelial dysfunction on white matter hyperintensity. J. Am. Heart Assoc. 10, e021066 (2021).
Google Scholar
Khatri, M. et al. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke 38, 3121–3126 (2007).
Google Scholar
Moroni, F. et al. Cardiovascular disease and brain health: focus on white matter hyperintensities. Int. J. Cardiol. Heart Vasc. 19, 63–69 (2018).
Google Scholar
Dight, J., Zhao, J., Styke, C., Khosrotehrani, K. & Patel, J. Resident vascular endothelial progenitor definition and function: the age of reckoning. Angiogenesis 25, 15–33 (2022).
Google Scholar
Han, Y. & Kim, S. Y. Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics. Exp. Mol. Med. 55, 1–12 (2023).
Google Scholar
Faraco, G. et al. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature 574, 686–690 (2019).
Google Scholar
Kresge, H. A. et al. Subclinical compromise in cardiac strain relates to lower cognitive performances in older adults. J. Am. Heart Assoc. 7, e007562 (2018).
Google Scholar
Moore, E. E. & Jefferson, A. L. Impact of cardiovascular hemodynamics on cognitive aging. Atheroscler. Thromb. Vasc. Biol. 41, 1255–1264 (2021).
Google Scholar
van Osch, M. J. P. et al. Human brain clearance imaging: pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood. NMR Biomed. 37, e5159 (2024).
Google Scholar
Agarwal, N. et al. Current understanding of the anatomy, physiology, and magnetic resonance imaging of neurofluids: update from the 2022 “ISMRM Imaging Neurofluids Study group” workshop in Rome. J. Magn. Reson. Imaging 59, 431–449 (2024).
Google Scholar
Licastro, E. et al. Glymphatic and lymphatic communication with systemic responses during physiological and pathological conditions in the central nervous system. Commun. Biol. 7, 229 (2024).
Google Scholar
Rego, S., Sanchez, G. & Da Mesquita, S. Current views on meningeal lymphatics and immunity in aging and Alzheimer’s disease. Mol. Neurodegener. 18, 55 (2023).
Google Scholar
Moonen, J. E. F. et al. Contributions of amyloid beta and cerebral small vessel disease in clinical decline. Alzheimers Dement. 20, 1868–1880 (2024).
Google Scholar
Pacholko, A. & Iadecola, C. Hypertension, neurodegeneration, and cognitive decline. Hypertension 81, 991–1007 (2024).
Google Scholar
Coomans, E. M. et al. Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation. Brain 147, 949–960 (2024).
Google Scholar
Yau, W. W. et al. Tau mediates synergistic influence of vascular risk and Aβ on cognitive decline. Ann. Neurol. 92, 745–755 (2022).
Google Scholar
Nho, K. et al. Altered bile acid profile in mild cognitive impairment and Alzheimer’s disease: relationship to neuroimaging and CSF biomarkers. Alzheimers Dement. 15, 232–244 (2019).
Google Scholar
Nho, K. et al. Association of altered liver enzymes with alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw. Open 2, e197978 (2019).
Google Scholar
Myers, S. J., Jimenez-Ruiz, A., Sposato, L. A. & Whitehead, S. N. Atrial cardiopathy and cognitive impairment. Front. Aging Neurosci. 14, 914360 (2022).
Google Scholar
Roberts, K. F. et al. Amyloid-β efflux from the central nervous system into the plasma. Ann. Neurol. 76, 837–844 (2014).
Google Scholar
Tian, D. Y. et al. Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s disease. Mol. Psychiatry 26, 6074–6082 (2021).
Google Scholar
Xiang, Y. et al. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease. Acta Neuropathol. 130, 487–499 (2015).
Google Scholar
Liu, Y. H. et al. Association between serum amyloid-beta and renal functions: implications for roles of kidney in amyloid-beta clearance. Mol. Neurobiol. 52, 115–119 (2015).
Google Scholar
Wang, Y.-R. et al. Associations between hepatic functions and plasma amyloid-beta levels — implications for the capacity of liver in peripheral amyloid-beta clearance. Mol. Neurobiol. 54, 2338–2344 (2016).
Google Scholar
Cheng, Y. et al. Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease. Acta Neuropathol. 145, 717–731 (2023).
Google Scholar
Chen, Y., Strickland, M. R., Soranno, A. & Holtzman, D. M. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron 109, 205–221 (2021).
Google Scholar
Nascimento, J. C. R. et al. Impact of apolipoprotein E genetic polymorphisms on liver disease: an essential review. Ann. Hepatol. 19, 24–30 (2020).
Google Scholar
Liu, C. C. et al. Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function. Nat. Neurosci. 25, 1020–1033 (2022).
Google Scholar
Ehtezazi, T., Rahman, K., Davies, R. & Leach, A. G. The pathological effects of circulating hydrophobic bile acids in Alzheimer’s disease. J. Alzheimers Dis. Rep. 7, 173–211 (2023).
Google Scholar
Horowitz, A. M. et al. Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain. Science 369, 167–173 (2020).
Google Scholar
Shi, M. et al. CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease. Alzheimers Dement. 12, 1125–1131 (2016).
Google Scholar
Tarasoff-Conway, J. M. et al. Clearance systems in the brain-implications for Alzheimer disease. Nat. Rev. Neurol. 11, 457–470 (2015).
Google Scholar
Wang, J. et al. Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies. Acta Neuropathol. 136, 525–536 (2018).
Google Scholar
Mielke, M. M. et al. Performance of plasma phosphorylated tau 181 and 217 in the community. Nat. Med. 28, 1398–1405 (2022).
Google Scholar
Semmler, A. et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J. Neuroinflammation 5, 38 (2008).
Google Scholar
Rankin, L. C. & Artis, D. Beyond host defense: emerging functions of the immune system in regulating complex tissue physiology. Cell 173, 554–567 (2018).
Google Scholar
Rock, K. L., Latz, E., Ontiveros, F. & Kono, H. The sterile inflammatory response. Annu. Rev. Immunol. 28, 321–342 (2010).
Google Scholar
van Eeden, S. F. & Sin, D. D. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 75, 224–238 (2008).
Google Scholar
Benakis, C. et al. The microbiome-gut-brain axis in acute and chronic brain diseases. Curr. Opin. Neurobiol. 61, 1–9 (2020).
Google Scholar
Chen, L. et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9, 7204–7218 (2018).
Google Scholar
Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832 (2019).
Google Scholar
Venereau, E., Ceriotti, C. & Bianchi, M. E. DAMPs from cell death to new life. Front. Immunol. 6, 422 (2015).
Google Scholar
Zindel, J. & Kubes, P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu. Rev. Pathol. 15, 493–518 (2020).
Google Scholar
Oudijk, E. J., Lammers, J. W. & Koenderman, L. Systemic inflammation in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 46, 5s–13s (2003).
Google Scholar
Brezzo, G., Simpson, J., Ameen-Ali, K. E., Berwick, J. & Martin, C. Acute effects of systemic inflammation upon the neuro-glial-vascular unit and cerebrovascular function. Brain Behav. Immun. Health 5, 100074 (2020).
Google Scholar
Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803–815 (2007).
Google Scholar
Amersfoort, J., Eelen, G. & Carmeliet, P. Immunomodulation by endothelial cells — partnering up with the immune system? Nat. Rev. Immunol. 22, 576–588 (2022).
Google Scholar
Chen, B. R., Kozberg, M. G., Bouchard, M. B., Shaik, M. A. & Hillman, E. M. A critical role for the vascular endothelium in functional neurovascular coupling in the brain. J. Am. Heart Assoc. 3, e000787 (2014).
Google Scholar
Smith, B. C., Tinkey, R. A., Shaw, B. C. & Williams, J. L. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system. Immunol. Rev. 311, 39–49 (2022).
Google Scholar
Tarantini, S., Tran, C. H. T., Gordon, G. R., Ungvari, Z. & Csiszar, A. Impaired neurovascular coupling in aging and Alzheimer’s disease: contribution of astrocyte dysfunction and endothelial impairment to cognitive decline. Exp. Gerontol. 94, 52–58 (2017).
Google Scholar
Iadecola, C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96, 17–42 (2017).
Google Scholar
Banks, W. A., Kastin, A. J. & Broadwell, R. D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2, 241–248 (1995).
Google Scholar
Sama, M. A. et al. Interleukin-1β-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J. Biol. Chem. 283, 21953–21964 (2008).
Google Scholar
Xie, D. et al. IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats. Glia 64, 583–602 (2016).
Google Scholar
Zelenay, S. & Reis e Sousa, C. Adaptive immunity after cell death. Trends Immunol. 34, 329–335 (2013).
Google Scholar
Cramer, J. V., Benakis, C. & Liesz, A. T cells in the post-ischemic brain: troopers or paramedics? J. Neuroimmunol. 326, 33–37 (2019).
Google Scholar
Kunzli, M. & Masopust, D. CD4+ T cell memory. Nat. Immunol. 24, 903–914 (2023).
Google Scholar
Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).
Google Scholar
van Zeventer, I. A. et al. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged >/=80 years. Blood Adv. 5, 2115–2122 (2021).
Google Scholar
Avagyan, S. & Zon, L. I. Clonal hematopoiesis and inflammation — the perpetual cycle. Trends Cell Biol. 33, 695–707 (2023).
Google Scholar
Bouzid, H. et al. Clonal hematopoiesis is associated with protection from Alzheimer’s disease. Nat. Med. 29, 1662–1670 (2023).
Google Scholar
Santisteban, M. M. et al. Meningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension. Nat. Neurosci. 27, 63–77 (2024).
Google Scholar
Uekawa, K. et al. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress. Mol. Neurodegener. 18, 73 (2023).
Google Scholar
Schonhoff, A. M. et al. Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease. Nat. Commun. 14, 3754 (2023).
Google Scholar
Mildenberger, W., Stifter, S. A. & Greter, M. Diversity and function of brain-associated macrophages. Curr. Opin. Immunol. 76, 102181 (2022).
Google Scholar
De Maeyer, R. P. H. & Chambers, E. S. The impact of ageing on monocytes and macrophages. Immunol. Lett. 230, 1–10 (2021).
Google Scholar
Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 69, S4–9 (2014).
Google Scholar
Huber, J. D., Campos, C. R., Mark, K. S. & Davis, T. P. Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after λ-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol. 290, H732–H740 (2006).
Google Scholar
Purchiaroni, F. et al. The role of intestinal microbiota and the immune system. Eur. Rev. Med. Pharmacol. Sci. 17, 323–333 (2013).
Google Scholar
Lynch, S. V., Ng, S. C., Shanahan, F. & Tilg, H. Translating the gut microbiome: ready for the clinic? Nat. Rev. Gastroenterol. Hepatol. 16, 656–661 (2019).
Google Scholar
Violi, F., Castellani, V., Menichelli, D., Pignatelli, P. & Pastori, D. Gut barrier dysfunction and endotoxemia in heart failure: a dangerous connubium? Am. Heart J. 264, 40–48 (2023).
Google Scholar
Hufnagl, K., Pali-Scholl, I., Roth-Walter, F. & Jensen-Jarolim, E. Dysbiosis of the gut and lung microbiome has a role in asthma. Semin. Immunopathol. 42, 75–93 (2020).
Google Scholar
Wieland, A., Frank, D. N., Harnke, B. & Bambha, K. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Alimentary Pharmacol. Ther. 42, 1051–1063 (2015).
Google Scholar
Sharma, S. & Tripathi, P. Gut microbiome and type 2 diabetes: where we are and where to go? J. Nutr. Biochem. 63, 101–108 (2019).
Google Scholar
Hosang, L. et al. The lung microbiome regulates brain autoimmunity. Nature 603, 138–144 (2022).
Google Scholar
Colombo, A. V. et al. Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition. eLife 10, e59826 (2021).
Google Scholar
Aho, V. T. E. et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease. Mol. Neurodegener. 16, 6 (2021).
Google Scholar
Ho, L. et al. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms. Expert Rev. Neurother. 18, 83–90 (2018).
Google Scholar
Han, Y. et al. Vagus nerve and underlying impact on the gut microbiota-brain axis in behavior and neurodegenerative diseases. J. Inflamm. Res. 15, 6213–6230 (2022).
Google Scholar
Tan, A. H., Lim, S. Y. & Lang, A. E. The microbiome-gut-brain axis in Parkinson disease — from basic research to the clinic. Nat. Rev. Neurol. 18, 476–495 (2022).
Google Scholar
Svensson, E. et al. Vagotomy and subsequent risk of Parkinson’s disease. Ann. Neurol. 78, 522–529 (2015).
Google Scholar
Kim, S. et al. Transneuronal propagation of pathologic α-synuclein from the gut to the brain models Parkinson’s disease. Neuron 103, 627–641.e7 (2019).
Google Scholar
Kjelvik, G. et al. Public knowledge about dementia risk reduction in Norway. BMC Public Health 22, 2046 (2022).
Google Scholar
De Krom, F. J. W. et al. Awareness of dementia risk reduction among current and future healthcare professionals: a survey study. J. Public Health Res. 10, 1961 (2021).
Google Scholar
Harkness, K. et al. Cognitive function and self-care management in older patients with heart failure. Eur. J. Cardiovasc. Nurs. 13, 277–284 (2014).
Google Scholar
van Nieuwkerk, A. C. et al. Cognitive impairment in patients with cardiac disease: implications for clinical practice. Stroke 54, 2181–2191 (2023).
Google Scholar
Wong, M. D., Shapiro, M. F., Boscardin, W. J. & Ettner, S. L. Contribution of major diseases to disparities in mortality. N. Engl. J. Med. 347, 1585–1592 (2002).
Google Scholar
Barthelemy, N. R. et al. Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests. Nat. Med. 30, 1085–1095 (2024).
Google Scholar
Okuzumi, A. et al. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies. Nat. Med. 29, 1448–1455 (2023).
Google Scholar
Wolters, F. J. et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer cohorts consortium. Neurology 95, e519–e531 (2020).
Google Scholar
Wang, L. et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018. JAMA 326, 1–13 (2021).
Google Scholar
An, E. et al. Stress-resilience impacts psychological wellbeing as evidenced by brain–gut microbiome interactions. Nat. Ment. Health 2, 935–950 (2024).
Google Scholar
Oh, H. S. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164–172 (2023).
Google Scholar
Whitlock, E. L. et al. Association of coronary artery bypass grafting vs percutaneous coronary intervention with memory decline in older adults undergoing coronary revascularization. JAMA 325, 1955–1964 (2021).
Google Scholar
Kalantarian, S., Stern, T. A., Mansour, M. & Ruskin, J. N. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann. Intern. Med. 158, 338–346 (2013).
Google Scholar
Johansen, M. C. et al. Risk of dementia associated with atrial cardiopathy: the ARIC study. JAHA 11, e025646 (2022).
Google Scholar
Hort, J. et al. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Eur. J. Neurol. 17, 1236–1248 (2010).
Google Scholar
Johansen, M. C. et al. Associations between left ventricular structure, function, and cerebral amyloid: the ARIC-PET study. Stroke 50, 3622–3624 (2019).
Google Scholar
Sible, I. J., Nation, D. A. & Alzheimer’s Disease Neuroimaging Initiative. Visit-to-visit blood pressure variability and longitudinal tau accumulation in older adults. Hypertension 79, 629–637 (2022).
Google Scholar
Biessels, G. J., Nobili, F., Teunissen, C. E., Simo, R. & Scheltens, P. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol. 19, 699–710 (2020).
Google Scholar
Nelson, P. T. et al. Human cerebral neuropathology of type 2 diabetes mellitus. Biochim. Biophys. Acta 1792, 454–469 (2009).
Google Scholar
link
